{
    "ticker": "NAVB",
    "name": "Navidea Biopharmaceuticals, Inc.",
    "description": "Navidea Biopharmaceuticals, Inc. is a specialized biopharmaceutical company focused on the development and commercialization of precision medicine for the diagnosis and treatment of various diseases. Founded in 1983 and headquartered in Dublin, Ohio, Navidea is dedicated to advancing the field of molecular imaging and therapeutic delivery. The company\u2019s flagship product, Lymphoseek, is a radiopharmaceutical designed to assist in the identification of sentinel lymph nodes in patients with cancer, significantly enhancing the accuracy of surgical procedures. In addition to Lymphoseek, Navidea is actively developing other innovative diagnostic imaging agents and therapeutics that target diseases with high unmet medical needs, including Alzheimer's disease and autoimmune disorders. With a strong emphasis on research and development, Navidea collaborates with leading academic institutions and industry partners to expand its product pipeline and bring novel solutions to market. The company is committed to improving patient outcomes through its targeted therapies and diagnostic tools, thereby transforming the landscape of healthcare.",
    "industry": [
        "Biopharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "Dublin, Ohio, USA",
    "founded": "1983",
    "website": "https://www.navidea.com",
    "ceo": "Rick Gonzalez",
    "social_media": {
        "twitter": "https://twitter.com/NavideaBio",
        "linkedin": "https://www.linkedin.com/company/navidea-biopharmaceuticals/"
    },
    "investor_relations": "https://www.navidea.com/investor-relations",
    "key_executives": [
        {
            "name": "Rick Gonzalez",
            "position": "CEO"
        },
        {
            "name": "Michael A. McGarrity",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Radiopharmaceuticals",
            "products": [
                "Lymphoseek"
            ]
        },
        {
            "category": "Diagnostic Imaging Agents",
            "products": [
                "NAV4694"
            ]
        }
    ],
    "seo": {
        "meta_title": "Navidea Biopharmaceuticals, Inc. | Innovating Precision Medicine",
        "meta_description": "Learn about Navidea Biopharmaceuticals, Inc., a leader in precision medicine and molecular imaging. Explore their innovative products and commitment to healthcare advancements.",
        "keywords": [
            "Navidea",
            "Biopharmaceuticals",
            "Molecular Imaging",
            "Lymphoseek",
            "Healthcare Innovation"
        ]
    },
    "faq": [
        {
            "question": "What is Navidea Biopharmaceuticals known for?",
            "answer": "Navidea Biopharmaceuticals is known for its innovative radiopharmaceuticals, particularly Lymphoseek, for cancer surgery."
        },
        {
            "question": "Who is the CEO of Navidea?",
            "answer": "Rick Gonzalez is the CEO of Navidea Biopharmaceuticals, Inc."
        },
        {
            "question": "Where is Navidea headquartered?",
            "answer": "Navidea is headquartered in Dublin, Ohio, USA."
        },
        {
            "question": "What are Navidea's main products?",
            "answer": "Navidea's main products include Lymphoseek and NAV4694."
        },
        {
            "question": "When was Navidea founded?",
            "answer": "Navidea Biopharmaceuticals was founded in 1983."
        }
    ],
    "competitors": [
        "JNJ",
        "MRK",
        "ABBV",
        "BMY"
    ],
    "related_stocks": [
        "PFE",
        "AMGN",
        "GILD",
        "REGN"
    ]
}